A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects
Clinical trial NCT05819710 · COMPLETED
Trial details
- NCT number
- NCT05819710
- Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2023-08-25
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.